Android app on Google Play

Barclays Maintains an 'Overweight' on Aetna (AET) After Hosting Meeting with Management

May 15, 2012 3:06 PM EDT Send to a Friend
Get Alerts AET Hot Sheet
Price: $81.93 -0.24%

Rating Summary:
    11 Buy, 7 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 24 | Down: 14 | New: 52
Trade AET Now!
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Aetna (NYSE: AET) price target of $59.00.

Analyst, Joshua R. Raskin, said, "Since it reported first quarter 2012 earnings on April 26, 2012, shares of AET have declined 15.9% (with the broader market down 3.8%). Clearly, the quarter was not well received. The company has also had the chance to meet with several groups of investors over the past two weeks and is presenting at a competitor conference this week. After spending the day with the company, we concluded that investors simply won't gain comfort in the year until there is a better read on 2Q12 results."

Raskin continues to be bullish on shares, confident in assets, acceleration in medical costs, and current valuation of AET is under 8x 2013 EPS estimates.

For an analyst ratings summary and ratings history on Aetna click here. For more ratings news on Aetna click here.

Shares of Aetna closed at $41.53 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View

Related Entities

Barclays, Earnings

Add Your Comment